SARS-CoV-2 and its ACE2 receptor

The SARS-CoV-2 virus enters the human host cell via the receptor ACE2 and uses the serine protease TMPRSS2 for S protein priming. The ACE2 usage has been shown to be crucial for transmissibility of other coronaviruses. Much research into the COVID-19 pandemic focuses on understanding the complex process of virus entry.

January 13, 2021

Neuroinvasion of SARS-CoV-2 in human and mouse brain

The Journal of Experimental Medicine
Eric SongAkiko Iwasaki
January 11, 2021

Endothelial cells and SARS-CoV-2: An intimate relationship

Vascular Pharmacology
Lucas Cunha BarbosaValéria Pereira Ferrer
January 13, 2021

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Nature Communications
Jiwan GeLinqi Zhang
January 10, 2021

Circulating cardiovascular microRNAs in critically ill COVID-19 patients Short title: microRNA signatures in COVID-19

European Journal of Heart Failure
Ankita GargThomas Thum
January 12, 2021

SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development

Expert Review of Clinical Pharmacology
Chiranjib ChakrabortyGovindasamy Agoramoorthy
January 11, 2021
Open Access

Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2 and heparan sulfate

BioRxiv : the Preprint Server for Biology
E. Prieto-FernandezAsis Palazon
January 11, 2021

Exposure to particulate matter upregulates ACE2 and TMPRSS2 expression in the murine lung

Environmental Research
Tomoya SagawaHirohisa Takano
January 12, 2021
Open Access

Altered kidney function and acute kidney damage markers predict survival outcomes of COVID-19 patients: A prospective pilot study.

MedRxiv : the Preprint Server for Health Sciences
Mustafa Zafer TemizA. Y. Muslumanoglu
January 12, 2021

ACE2-derived peptides interact with the RBD domain of SARS-CoV-2 spike glycoprotein, disrupting the interaction with the human ACE2 receptor

Journal of Biomolecular Structure & Dynamics
Pedro F N SouzaCleverson D T Freitas
January 11, 2021

Human SARS CoV-2 spike protein mutations

Lalitha Guruprasad
January 9, 2021
Open Access

Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2

Journal of Translational Medicine
Abul Bashar Mir Md Khademul IslamA M A M Zonaed Siddiki
January 12, 2021

Friend or Foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment

Obesity Medicine
Juan PangTianru Jin
January 11, 2021
Open Access

Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment

BioRxiv : the Preprint Server for Biology
M. H. ChengIvet Bahar
January 12, 2021

Predictive medicinal metabolites from Momordica dioica against comorbidity related proteins of SARS-CoV-2 infections

Journal of Biomolecular Structure & Dynamics
Chavan SakshiV Veena
January 12, 2021

Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients

Reviews in Medical Virology
Mohammad Mahmudur RahmanAsif Ahmed
January 10, 2021

Expression of SARS-CoV-2 entry factors in human oral tissue

Journal of Anatomy
Yoshihiko SawaHiroyuki Harada

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.


Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

© 2021 Meta ULC. All rights reserved